Specify a stock or a cryptocurrency in the search bar to get a summary
Vetoquinol
VETOVetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA. Address: Magny-Vernois, Lure, France, 70204
Analytics
WallStreet Target Price
91.58 EURP/E ratio
20.5764Dividend Yield
1.07 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures VETO
Dividend Analytics VETO
Dividend growth over 5 years
74 %Continuous growth
1 yearPayout Ratio 5 years average
18 %Dividend History VETO
Stock Valuation VETO
Financials VETO
Results | 2019 | Dynamics |